olivLaw · US equity research
Gabelli Healthcare & WellnessRx Trust GRX
At the close of 02 Nov 2026, Gabelli Healthcare & WellnessRx Trust (GRX) stock was 10.20 USD (+0.69% on the day), with beta 0.38, 52-week range 8.87–10.20 USD.
Data as of · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 68.9
- strong (55–70)
- Bollinger (20, 2)
- 9.40 – 10.36
- in the upper half of the band · %B 0.83 · band width 9.7%
- SMA 50 / 200
- 9.84 / 9.53
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 0.11 / 0.08
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +8.7% | −2.3% | +11.1 pp | — |
| 3 months | +5.0% | −0.8% | +5.8 pp | — |
| 6 months | +12.8% | +4.7% | +8.1 pp | — |
| Year to date | +5.9% | +10.2% | −4.2 pp | — |
| 1 year | +9.7% | +10.3% | −0.6 pp | — |
| 3 years | +22.3% | +73.0% | −50.7 pp | — |
| 5 years | −25.5% | +61.8% | −87.3 pp | — |
Price returns, dividends excluded.
Quarterly results
unavailable
Reported results vs expectations
Loading…
Balance sheet & financial health
Valuation
unavailable
Versus the vertical median
Not enough comparable companies with data for an average.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report07 May 2026Other events · Financial statements and exhibits
- Proxy statement19 Mar 2026
- Proxy statement20 Mar 2025
- Proxy statement22 Mar 2024
- Proxy statement05 Apr 2023
- Proxy statement24 Mar 2022
- Proxy statement29 Mar 2021
- Proxy statement26 Mar 2020
- Proxy statement29 Mar 2019
- Proxy statement28 Mar 2018
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.